- Show all
- Abigail Coursolle
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amy Chen
- Andy DiAntonio
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charly Gilfoil
- Corey Davis
- Dania Douglas
- Daniel Young
- daryln
- David Machledt
- Elizabeth Edwards
- Elizabeth G. Taylor
- Eskedar Girmash
- Fabiola Carrión
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Kasey Nichols
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Lisa Munoz
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- April 14, 2022
NHeLP comments on Oregon’s application for renewal of the Oregon Health Plan § 1115(a) Demonstration Waiver for 2022-2027
Read moreIn public comments, NHeLP expresses support for Oregon's decision to abandon its waiver of EPSDT. However, NHeLP strongly opposes Oregon's proposal to exclude outpatient prescription drugs approved under the FDA's accelerated approval pathway. Denying Medicaid enrollees access to effective break-through therapies would harm people with serious or life-threatening medical…
- April 12, 2022
NHeLP Comments on the Proposed Update to the CDC’s Opioid Prescribing Guidelines
Read moreIn these comments to the Centers for Disease Control and Prevention (CDC), NHeLPs conveys its support for the CDC's proposal to update the 2016 Opioid Prescribing Guidelines. NHeLP's comments highlight the negative consequences the 2016 guidelines have had on access to medically necessary opioid medications for pain, particularly for…
- April 8, 2022
More Transparency Needed to Ensure Medicaid Beneficiaries Have Access to Necessary Off-Label Prescription Drugs
Read moreUnder federal law, state Medicaid programs are required to cover (with a few exceptions) outpatient prescription drugs for “medically accepted indications.” Medically accepted indications are both those that are included on the drug’s label by the FDA as part of the approval process, and certain “off-label” uses.Medicaid programs are…
- February 11, 2022
NHeLP letter to HHS Sec. Becerra – Re: Advancing Health Equity Through Essential Health Benefits
Read moreThe Affordable Care Act (ACA) established a comprehensive set of ten Essential Health Benefits (EHB) that most health plans must cover. However, regulations allowing states to define EHB through a benchmarking process have lead to inconsistent and inadequate coverage. In this letter to HHS Secretary Xavier Becerra, NHeLP urges…
- December 9, 2021
Contraceptive Equity Primers
Read moreState Contraceptive Equity laws can play a critical role in filling the remaining gaps from the Affordable Care Act, and have the potential to expand equitable access to contraceptive services for all. This series of primers is designed to educate advocates and policymakers on the basics of Contraceptive Equity…
- December 7, 2021
Model Contraceptive Equity Act: Legislative Language and Issue Brief
Read moreUPDATED - December 2021. Contraceptive Equity is a policy framework under which contraceptive care is easily accessible and covered at no cost in all health plans. This paper begins with the Model Contraceptive Equity Act legislative language that can serve as a template for state advocates. It concludes with…
